ArticleJournal for immunotherapy of cancer2020

Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.